Introduction
Insulin stimulates the uptake of glucose from the blood into peripheral tissues, specifically skeletal muscle and adipose tissue. Skeletal muscle is quantitatively the most important tissue involved in maintaining glucose homoeostasis, and accounts for approx. 80% of glucose disposal after a glucose infusion or ingestion [1, 2] . Glucose homoeostasis is impaired in patients with non-insulin-dependent diabetes mellitus (NIDDM) as the result of, at least in part, a defect in glucose disposal [3] . In nivo studies utilizing the euglycaemicl hyperinsulinaemic clamp technique demonstrated that one of the first measurable defects associated with NIDDM is insulin-resistance in skeletal muscle [3] . Using in nitro skeletal-muscle preparations, this defect can be localized to the level of glucose transport [4, 5] , since insulin-stimulated glucose transport is markedly reduced in skeletal muscle from patients with NIDDM and obese individuals. Glucose transport is an early step in peripheral glucose utilization, which is proximal to oxidative and non-oxidative metabolism, thus defective transport most likely plays a major role in the pathogenesis of peripheral insulin-resistance which is characteristic of obesity and NJDDM. Therefore undertstanding the mechanisms that control insulin stimulation of glucose transport into insulin-sensitive tissues is essential to develop strategies for re-establishing normal glucose homoeostasis in people with peripheral insulin-resistance. The following discussion focuses on the effects of modified GLUT4 expression in skeletal muscle on cellular function and whole-body glucose metabolism.
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Glucose transporters in skeletal muscle
Glucose transport into skeletal muscle is ratelimiting for glucose utilization under physiological conditions [6] , and is defective in NIDDM [4] . G L U T l and GLUT4 are the two structurally related glucose-transporter isoforms expressed in insulin-sensitive tissue such as skeletal muscle [7] . In skeletal muscle, G L U T l has been reported to reside constitutively in perineural sheaths [8, 9] and endoneurial vessels [lo] . Relatively low levels of G L U T l have been detected in skeletal-muscle plasma membranes from rodents [11, 12] and humans [13] . Thus the contribution of G L U T l to total glucose transport in insulin-sensitive tissues such as skeletal muscle is minimal, as this transporter appears to primarily mediate the basal glucose transport and/or the transport of glucose to the nerve fibres [4, 12] .
GLUT4 is the predominant glucose-transporter isoform expressed in insulin-sensitive tissues such as skeletal muscle [14, 15] . In skeletal muscle, GLUT4 is rapidly translocated to the cell surface in response to insulin stimulation [ 13, 16, 17] . GLUT4 translocation to the plasma membrane is also mediated by muscle contractions [ 111 and hypoxia [ 181. Several groups have shown that GLUT4 translocation accounts for nearly all the increase in glucose uptake in skeletal muscle [19] .
In humans, neither mild obesity nor diabetes leads to alterations in GLUT4 mRNA or protein in skeletal muscle [ZO] . Thus impaired function or distribution of GLUT4 may be a factor accounting for the development of insulinresistance in skeletal muscle from patients with NIDDM [4]. The reduced insulin-stimulated glucose uptake in skeletal muscle associated with insulin-resistant states such as obesity [21] and NIDDM [22] may result from defects in the signalling pathway leading to GLUT4 translocation, or from alterations in the intracellular traffic of GLUT4 transporters to the plasma membrane. Because GLUT4 is dysregulated in skeletal muscle from NIDDM and obese individuals with peripheral insulin-resistance, understanding the signalling systems involved in GLUT4 traffic and I997 translocation is essential in order to identify effective strategies to maintain whole-body glucose homoeostasis in insulin-resistant states. Utilizing transgenic and gene knock-out mouse models is one effective way to understand the importance of skeletal-muscle GLUT4 in glucose homoeostasis.
Genetic manipulation of GLUT4 in mice
Recent studies in which G L U T l and GLUT4 has been overexpressed in transgenic mice demonstrate two very important findings: (1) glucose transport is rate-limiting for muscle glucose disposal and (2) the level of muscle GLUT4 affects the maximal rate of whole-body glucose disposal in normal and diabetic mice [23] . These studies underscore the importance of GLUT4 in skeletal muscle for maintaining glucose homoeostasis and implicate GLUT4 as an attractive target for therapy. T o assess the role of GLUT4 in glucose homoeostasis, we have disrupted the murine GLUT4 gene (GLUT4 null) [24] . Genetic ablation of GLUT4 was expected to result in abnormal glucose homoeostasis, but surprisingly, the GLUT4 null mice maintain normal blood glucose levels. Furthermore oral glucose-tolerance tests show that the GLUT4 null mice clear glucose as efficiently as controls, but insulin-tolerance tests indicate that GLUT4 null mice are less sensitive to insulin action [24] . Preliminary results from euglycaemic/ hyperinsulaemic clamp studies confirm that GLUT4 null mice are indeed insulin-resistant (J. Li, T.-S. Tsao, R. Burcelin and M. J. Charron, unpublished work). As a consequence of the diminished insulin-stimulated glucose uptake in the GLUT4 null muscle, glycogen stores and glycogen synthesis are also reduced [25] . Another indication of reduced muscle glucose uptake and metabolism is a decrease in the fed serum lactate level in GLUT4 null mice compared with normal [24] . The GLUT4 null mice have developed a compensatory mechanism(s) to maintain glucose homoeostasis, which may involve the activation of a novel glucose-transporter system and/or alterations in signalling mechanism(s) involved in maintaining glucose transport into muscle cells. Identifying the adaptive mechanism(s) that arise from GLUT4 ablation can be useful in developing strategies to prevent or reduce the skeletal-muscle insulinresistance associated with obesity and NIDDM.
Although the extensor digitorum longus (EDL) muscles of the GLUT4 null mice exhibit almost no insulin-stimulated glucose uptake in vitro, the soleus muscles express a compensatory insulin-stimulated glucose-transport activity [25]. The female soleus muscle exhibits a 2-fold increase in insulin-stimulated glucose uptake in vitro. Curiously, the male GLUT4 null soleus muscle displays a 2-fold increase in basal glucose uptake with no further increase on insulin stimulation. Preliminary studies demonstrate that the compensatory system is fully inhibited by incubation with 50 pM cytochalasin B (J. R. Zierath, A. E. Stenbit, T.-S. Tsao and M. J. Charron, unpublished work) . This suggests that the transport of glucose into the GLUT4 null soleus muscle is catalysed by a facilitated carrier and not by passive diffusion. At present, the molecular mechanism underlying the sexually dimorphic response to GLUT4 ablation is unknown. In the GLUT4 null mice, the compensatory glucose-transport system is not due to an increased expression of G L U T l or any of the other known facilitative glucose-transporter proteins [25, 25] . It is possible that either an alteration in G L U T l traffic or activity, or the activation of a novel glucose transporter (i.e. GLUTX), is responsible for this increase in glucose-transport activity in the muscle from the GLUT4 null mice.
We have generated and characterized transgenic mice in which GLUT4 has been exclusively overexpressed 3-4-fold in fast-twitch skeletal muscle (ie. EDL), but not slow-twitch skeletal muscle (i.e. soleus), using the myosin light chain 1 promoter (MLC) to drive GLUT4 expression [26, 27] . T h e MLC-GLUT4 mice exhibit enhanced insulin action and glucose disposal at both the cellular level in skeletal muscle, as measured by 2-deoxyglucose (2-GOD) transport in isolated muscle, and at the whole-body level, as measured by the euglycaemidhyperinsulinaemic clamp technique. MLC-GLUT4 mice have been mated to GLUT4 null mice to generate mice that express GLUT4 only in muscle (MLC-GLUT4 null mice) [28] . MLC-GLUT4 null mice have normal glucose and insulin levels and normal insulin-tolerance. T h e restoration of GLUT4 in fast-twitch skeletal muscle appears to be sufficient for normalization of the altered glucose metabolism seen in the muscles of the insulin-resistant GLUT4 null mice. As an indication of increased skeletal-muscle glucose metabolism, MLC-GLUT4 null mice have restored fed serum lactate levels. Furthermore the activation or expression of the insulin-stimuVolume 25 lated glucose-transport activity detected in GLUT4 null soleus muscle is not dependent on the hyperinsulaemia observed in the null mice since in vitro 2-DOG uptake into soleus muscles of MLC-GLUT4 null mice yields results similar to those obtained with GLUT4 null muscles. Therefore the restoration of GLUT4 to fasttwitch skeletal muscle in MLC-GLUT4 null mice and the normalization of the metabolic milieu may be sufficient to restore cellular insulin signalling to these muscles.
G LUT4 traffic/translocation
In sketal muscle, glucose transport and GLUT4 translocation have been shown to be activated by two separate pathways: one stimulated by insulin "29-3 11, insulin-mimicking agents [ 3 11 and insulin-like growth factors [4], and one activated by exercise [29, 32] , hypoxia [30] or W-7, an agent that increases glucose transport by increasing cytoplasmic Ca2+ [33] . When the two pathways are stimulated concurrently, the rate of glucose transport is increased in an additive manner [29] . Furthermore hyperglycaemia activates glucose transport by a Cazt-dependent pathway which is independent of phosphatidylinositol 3-kinase (PI 3-kinase), and is separate from the mass-action effect of glucose on glucose transport [34] . Acute hyperglycaemia has been shown to induce a 2-fold increase in plasma-membrane GLUT4 content, suggesting that in skeletal muscle there is also an insulinindependent autoregulation of the glucose-transport system [35] .
Many of the initial studies performed using subcellular fractionation techniques to isolate partially purified plasma membranes from intracellular microsomal membranes prepared from rat hindlimb skeletal muscle stimulated by insulin [ 111, muscle contractions [36, 37] or hypoxia [18] show that the transport of glucose into skeletal muscle is mediated by a process involving translocation of GLUT4 from an intracellular site to the plasma membrane. Recently, a membrane-impermeant photoaffinity reagent, 2-N-4-(1 -azi-2,2,2-trifluoroethyl) benzoyl-1,3-bis-(u-mannose-4-yloxy) -2-propylamine (ATB-BMPA), has been used to identify cellsurface glucose transporters in isolated rat adipocytes [38] and skeletal muscle [19] . One advantage of the photolabelling technique is that rates of glucose transport can be directly compared with the cell-surface glucose-transporter content. Using ATB-BMPA photolabelling and subsequent immunoprecipitation of GLUT4, the amount of GLUT4 at the cell surface has been shown to account fully for the increase in glucose uptake in skeletal muscle after stimulation with insulin or muscle contraction [19] . Recently, this procedure was used to assess cellsurface GLUT4 content in mouse skeletal muscles [33] . The utility of ATB-BMPA and other photolabelling reagents in the characterization of the compensatory glucose transporter expressed in highly oxidative GLUT4 null muscles remains to be tested.
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Signal transduction in skeletal muscle
Although both insulin and muscle contractions are well established as powerful stimulators of glucose transport [32] and GLUT4 translocation [4], the signalling mechanism involved in the activation of glucose transport by either of these two pathways is still somewhat undefined. T h e earliest events that occur in the insulin signalling cascade are the phosphorylation of the insulin receptor (IR) and insulin receptor substrates-1 and -2 (IRS-1, IRS-2) and the activation of PI 3-kinase [39] . PI 3-kinase has been shown to act at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-Ll cells [40] . Elements of the insulin signalling pathway have been studied in several animal models of insulinresistance. In hyperinsulinaemic states in rodents or humans, insulin-stimulated IR, IRS-1 and anti-phosphotyrosine-immunoprecipitable PI 3-kinase activity and 2-DOG uptake are all significantly decreased in skeletal muscle [41, 42] . In contrast, in hypoinsulinaemic streptozotocin-diabetic or fasted rats, phosphorylation of IR, IRS-1 and PI 3-kinase activity are increased in skeletal muscle [41, 42] . More recently, high-fat feeding in mice, which results in normoglycaemia with hyperinsulinaemia, leads to reduced insulinstimulated IRS-1-associated PI 3-kinase activity and reduced insulin-stimulated glucose transport in muscle [33] . The GLUT4 null mice present hyperinsulinaemia with normal serum glycaemia. Possibly the altered whole-body metabolic state and/or cellular metabolic consequences of ablation of GLUT4 may elicit changes in one or more elements of the insulin-signalling cascade in muscle from the GLUT4 null mice.
We have recently shown that IR autophosphorylation and tyrosine kinase activity are normal in EDL muscles of GLUT4 null despite GLUT4 ablation [ E l . However, it is not known whether IRS-1 phosphorylation or PI 3-kinase activity is altered by GLUT4 ablation. In the dexamethasone-treated rat, IR binding and phosphorylation in skeletal muscle have been shown to be intact, despite reduced PI 3-kinase activity [43] . Thus changes in PI 3-kinase activity can occur in skeletal muscle despite normal activity of IR. Since the soleus muscle develops a compensatory adaptation to the lack of GLUT4, changes in IR signalling including IRS-1 and IRS-2 phosphorylation, and PI 3-kinase activity may contribute to this adaptation. IRS-2 is also a substrate of the insulin receptor kinase and can bind PI 3-kinase [44] . Indeed, in IRS-1-deficient mice, IRS-2 tyrosine phosphorylation is significantly increased. Alterations in early signalling events may be involved in the compensatory changes that are present in the soleus from the GLUT4 null mice.
Insulin and exercise activate glucose transport by two different pathways [45] . T h e latter studies show that insulin/insulin-like growth factor I-stimulated glucose transport, but not exercise/hypoxia/muscle contraction-mediated glucose transport, is inhibited by wortmannin, a fungal metabolite that inhibits PI 3-kinase activity. Thus insulin and insulin-like growth fator I appear to activate glucose transport via the activation of receptor tyrosine kinase, phosphorylation of IRS-1, and activation of PI 3-kinase [4]. T h e precise mechanism for the activation of glucose transport by muscle contraction is still unknown, but appears to be initiated by an increase in cytoplasmic CaZ+ or it may be related to reduced levels of glycogen [32] . In addition to differences in the activation of glucose transport by these two pathways, there appears to be different mechanisms for the reversal of glucose transport when stimulated by either of these two pathways. The reversal of the insulin effect is rapid [46] , whereas exercise (e.g. swimming) has a persistent effect on glucosetransport activity which can be observed up to 18-22 h after the last bout of exercise [32] . Thus GLUT4 appears to play a critical role in normal glucose flux in resting and exercising skeletal muscle.
Our preliminary studies demonstrate that the glucose-transport system in GLUT4 null muscles is not sensitive to stimulation by exposure to hypoxia for 45 min (J. R. Zierath, T.-S.
Tsao, A. E. Stenbit, E. B. Katz and M. J. Charron, unpublished work). Physical exercise has two effects on glucose transport in skeletal muscle: the initial effect is an insulin-independent increase in glucose transport and the second phase consists of an increase in the sensitivity of the glucose-transport process to insulin [ 32, 471 . T h e insulin-independent effect of exercise can also be observed after stimulation of muscle with hypoxia [18] or in vitro contractions [30, 48] . Serum factors have been suggested to interact with the contracting muscle to enhance insulin sensitivity after a bout of swimming exercise [49] , since the enhanced insulin-sensitivity in muscle after exercise can only be observed after stimulation of muscle to contract in situ [18, 47] or after in vitro stimulation in the presence of serum [47] . Thus there may be differences in the mechanism for the activation of glucose transport by hypoxia and physical exercise. Whether the compensatory glucose transporter in GLUT4 null muscle responds to the exercise stimulus after acute bouts of swimming or treadmill running remains to be tested.
Summary
We have described mouse models in which the expression levels of GLUT4 in skeletal muscle have been modified. GLUT4 null mice, which lack skeletal-muscle GLUT4, are insulin-resistant. In contrast, MLC-GLUT4 mice, which overexpress GLUT4 specifically in the skeletal muscle, exhibit an increase in insulin-sensitivity and glucose disposal. Restoring GLUT4 expression specifically in the skeletal muscle of the GLUT4 null mice by mating with MLC-GLUT4 transgenic mice normalizes the reduced glucose uptake and glucose metabolism of the skeletal muscle of the MLC-GLUT4 null mouse. These models represent unique agents to dissect the mechanism for insulin signalling and GLUT4 translocation in skeletal muscle that expresses varying levels of GLUT4. 
Introduction
Glucose transport in muscle is carried out by the catalytic activity of two distinct glucose-transporter isoforms, GLUT4 and GLUT1. Expression of GLUT4 and G L U T l in muscles is developmentally regulated [ 1-41; whereas G L U T l expression largely decreases, GLUT4 increases during postnatal development. In adult life, GLUT4 is the main glucose carrier expressed in skeletal muscle, accounting for nearly 90% [S] . Under basal conditions, G L U T l and GLUT4 show a different subcellular distribution in skeletal muscle. G L U T l is found mainly in the sarcolemma of the muscle fibre, but not in transverse tubules (T-tubules) [5, 6] . In contrast, GLUT4 is mostly associated with intracellular membranous structures, as detected by immunoelecron microscopy of human vastus lateralis [7] , rat soleus [8-101 and rat extensor digitorum longus muscles [ 111. Intracellular GLUT4 is found in a perinuclear location close to the Golgi apparatus and in the proximity of the sarcolemma or the transverse tubules in rat extensor digitorum longus muscle [ 111. Analysis of the subcellular distribution in transgenic mice overexpressing GLUT4 by immunogold labelling Abbreviations used: ATP-BMPA, 2-,V-4-(1 -azi-Z,Z,Z-trifluoroethyI) benzyl-l,3-bis-(~-mannose-4-yloxy)-2-propylamine; SCAMP, secretory carrier membrane protein; SNARE, soluble n'-ethylmaleimidesensitive fusion protein (NSF) has revealed that most GLUT4 is located in and around the muscle triad [12] .
Currently available data indicate that insulin and exercise cause the translocation of GLUT4 glucose carriers in skeletal muscle. Immunocytochemical studies [7-lo] , subcellular fractionation [13-161 and photolabelling assays [17, 18] indicate that GLUT4 is translocated from an intracellular locus to the cell surface of the muscle fibre in response to insulin or exercise. With regard to the cell surface involved in insulininduced GLUT4 recruitment, it has been shown that GLUT4 is recruited to selective domains of the sarcolemma [8] [9] [10] 161 . Insulin also promotes the translocation of GLUT4 to the T-tubules of the muscle fibre as found by subcellular fractionation [ 16, 191 , immunoisolation of T-tubule vesicles [ 161, immunoelectron microscopy [7] or 2-A'-4-(l-azi-2,2,2-trifluoroethyl)benzyl-1,3-bis [2-j HI (r>-mannose-4-yloxy) -2-propylamine ATB-[2-jH]BMPA photolabelling followed by autoradiography [20] . Recent studies also indicate that insulin unmasks a C-terminal GLUT4 epitope in T-tubules in skeletal muscle [12] .
Rat cardiac myocytes express both GLUT4 and GLUT1, and, in contrast with skeletal muscle, G L U T l is expressed at a high level [21] . Immunoelectron microscopy studies performed in rat heart have shown that GLUT4 is localized in cardiac myocytes, under non-stimulated conditions, in small tubulovesicular elements adjacent to the sarcolemma and the T-tubular system, and in the trans-Golgi region [22] , and that insulin stimulates the recruitment of intracellular GLUT4 carriers to the sarcolemma and to the
